Bevacizumab for macular edema secondary to retinal vein occlusion: A systematic review and meta-analysis

Journal of Ocular Pharmacology and Therapeutics

Volumn 29, Issue 8, 2013, Pages 702-708

  Lu, Yi ^a   Su, Li ^a   Xu, Xun ^a  

^a SHANGHAI JIAO TONG UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

BEVACIZUMAB; TRIAMCINOLONE ACETONIDE;

CENTRAL MACULAR THICKNESS; CLINICAL ASSESSMENT; DRUG SAFETY; FOLLOW UP; HUMAN; INTRAOCULAR PRESSURE; LASER COAGULATION; META ANALYSIS; OUTCOME ASSESSMENT; RANDOMIZED CONTROLLED TRIAL (TOPIC); REFERENCE DATABASE; RETINA MACULA AGE RELATED DEGENERATION; RETINA MACULA EDEMA; RETINA VEIN OCCLUSION; REVIEW; SINGLE DRUG DOSE; STATISTICAL SIGNIFICANCE; SYSTEMATIC REVIEW; VISUAL ACUITY;

ANGIOGENESIS INHIBITORS; ANTIBODIES, MONOCLONAL, HUMANIZED; HUMANS; INTRAOCULAR PRESSURE; INTRAVITREAL INJECTIONS; MACULAR EDEMA; RANDOMIZED CONTROLLED TRIALS AS TOPIC; RETINAL VEIN OCCLUSION; TREATMENT OUTCOME; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 84885004807     PISSN: 10807683     EISSN: 15577732     Source Type: Journal    
DOI: 10.1089/jop.2013.0023     Document Type: Review

References (28)

1. Hayreh, S.S. Prevalent misconceptions about acute retinal vascular occlusive disorders. Prog. Retin. Eye. Res. 24:493-519, 2005
2. Mitchell, P., Smith, W., and Chang, A. Prevalence and associations of retinal vein occlusion in Australia. The Blue Mountains Eye Study. Arch. Ophthalmol. 114:1243-1247, 1996
3. Klein, R., Klein, B.E., Moss, S.E., et al. The epidemiology of retinal vein occlusion: the Beaver Dam Eye Study. Trans. Am. Ophthalmol. Soc. 98:133-141; discussion 141-133, 2000
4. Rogers, S., McIntosh, R.L., Cheung, N., et al. International Eye Disease Consortium. The prevalence of retinal vein occlusion: pooled data from population studies from the United States, Europe, Asia, and Australia. Ophthalmology. 117:313-319.e1, 2010
5. The Central Vein Occlusion Study Group. Nature history and clinical management of central retinal vein occlusion. Arch Ophthalmol. 115:486-491, 1997
6. Laouri, M., Chen, E., Looman, M., et al. The burden of disease of retinal vein occlusion: review of the literature. Eye. 25:981-988, 2011
7. Wong, T.Y., and Scott, I.U. Clinical practice. Retinal vein occlusion. N. Engl. J. Med. 363:2135-2144, 2010
8. Ehlers, J.P., and Fekrat, S. Retinal vein occlusion: beyond the acute event. Surv. Ophthalmol. 56:281-299, 2011
9. Ciulla, T., and Rosenfeld, P. Anti-vascular endothelial growth factor therapy for neovascular ocular diseases other than age-related macular degeneration. Curr. Opin. Ophthalmol. 20:166-174, 2009
10. Kriechbaum, K., Michels, S., Prager, F., et al. Intravitreal Avastin for macular oedema secondary to retinal vein occlusion: a prospective study. Br. J. Ophthalmol. 92:518-522, 2008
11. Badala, F. The treatment of branch retinal vein occlusion with bevacizumab. Curr. Opin. Ophthalmol. 19:234-238, 2008
12. Micieli, J.A., Micieli, A., and Smith, A.F. Identifying systemic safety signals following intravitreal bevacizumab: systematic review of the literature and the Canadian Adverse Drug Reaction Database. Can. J. Ophthalmol. 45:231-238, 2010
13. Dickersin, K., Scherer, R., and Lefebvre, C. Identifying relevant studies for systematic reviews. BMJ. 309:1286-1291, 1994
14. Jadad, A.R., Moore, R.A., Carroll, D., et al. Assessing the quality of reports of randomized clinical trials: is blinding necessary? Control. Clin. Trials. 17:1-12, 1996
15. Russo, V., Barone, A., Conte, E., et al. Bevacizumab compared with macular laser grid photocoagulation for cystoid macular edema in branch retinal vein occlusion. Retina. 29:511-515, 2009
16. Epstein, D.L., Algvere, P.V., von Wendt, G., et al. Bevacizumab for macular edema in central retinal vein occlusion: a prospective, randomized, double-masked clinical study. Ophthalmology. 119:1184-1189, 2012
17. Moradian, S., Faghihi, H., Sadeghi, B., et al. Intravitreal bevacizumab vs. sham treatment in acute branch retinal vein occlusion with macular edema: results at 3 months (Report 1). Graefes. Arch. Clin. Exp. Ophthalmol. 249:193-200, 2011
18. Wang, H.Y., Li, X., Wang, Y.S., et al. Intravitreal injection of bevacizumab alone or with triamcinolone acetonide for treatment of macular edema caused by central retinal vein occlusion. Int. J. Ophthalmol. 4:89-94, 2011
19. Cekic, O., Cakir, M., Yazici, A.T., et al. A comparison of three different intravitreal treatment modalities of macular edema due to branch retinal vein occlusion. Curr. Eye. Res. 35:925-929, 2010
20. Ding, X., Li, J., Hu, X., et al. Prospective study of intravitreal triamcinolone acetonide versus bevacizumab for macular edema secondary to central retinal vein occlusion. Retina. 31:838-845, 2011
21. Yilmaz, T., and Cordero-Coma, M. Use of bevacizumab for macular edema secondary to branch retinal vein occlusion: a systematic review. Graefes. Arch. Clin. Exp. Ophthalmol. 250: 787-793, 2012
22. Network Diabetic Retinopathy Clinical Research, Scott, I.U., Edwards, A.R., Beck, R.W., et al. A phase II randomized clinical trial of intravitreal bevacizumab for diabetic macular edema. Ophthalmology. 114:1860-1867, 2007
23. Fung, A.E., and Bhisitkul, R.B. Safety monitoring with ocular anti-vascular endothelial growth factor therapies. Br. J. Ophthalmol. 92:1573-1574, 2008
24. Martin, D.F., Maguire, M.G., Ying, G.S., et al. Ranibizumab and bevacizumab for neovascular age-related macular degeneration. N. Engl. J. Med. 364:1897-1908, 2011
25. Roth, D.B., King, A., Weiss, M., et al. Systemic adverse events after bevacizumab. Ophthalmology. 116:1226 e1221, 2009
26. Cxekic, O, Chang, S., Tseng, J.J., et al. Intravitreal triamcinolone treatment for macular edema associated with central retinal vein occlusion and hemiretinal vein occlusion. Retina. 25:846-850, 2005
27. Cxekic, O, Chang, S., Tseng, J.J., et al. Cataract progression after intravitreal triamcinolone injection. Am. J. Ophthalmol. 139:993-998, 2005
28. Soheilian, M., Ramezani, A., Obudi, A., et al. Randomized trial of intravitreal bevacizumab alone or combined with triamcinolone versus macular photocoagulation in diabetic macular edema. Ophthalmology. 116:1142-1150, 2009.